Lexaria Bioscience Earnings Analysis: Q1 Recap

Comments
Loading...

Lexaria Bioscience LEXX just disclosed its Q1 earnings on Friday, January 10, 2025 at 02:19 PM.

Here's a brief overview of the earnings report.

Earnings

Lexaria Bioscience missed estimated earnings by -33.0%, reporting an EPS of $-0.16 versus an estimate of $-0.12.

Revenue was up $32 thousand from the same period last year.

Earnings History Overview

During the previous quarter, the company missed on EPS by $0.04, leading to a 2.0% drop share price change the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Lexaria Bioscience visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!